Episode Details
Back to EpisodesResearch: Concussions, Plantar Fasciitis, Primary Mitochondrial Diseases, & Methylene Blue & Toluidine Blue Combats Cancer
Episode 147
Published 2 years, 1 month ago
Description
This week we are going to dig into some interesting research I've been compiling the last several months (and I have plenty more where this came from!). We will cover an array of our favorite topics in red light therapy, mitochondria and methylene blue.
We will first look at a piece of research that discusses primary mitochondrial diseases (PMDs); however, the article is directed towards physicians and how they can start to recognize patterns and red flags associated with various PMDs (i.e., mitochondrial dysfunction). To me this is extremely exciting in the sense that this type of mitochondrial information is (slowly but surely) permeating its way into the allopathic world. It can't happen fast enough!
The second article looks at methylene blue and a new, yet quite similar synthetic dye salt, blue compound called toluidine blue. The study looks at how when used together, they have a synergistic effect against oral squamous cell carcinoma. I need to know more about toluidine blue!
The third article looks at the effect of transcranial photobiomodulation on concussions. This study is a perfect example of a "non-result" not necessarily being a bad thing or that is should be taken at face value. I will discuss why.
The last, and likely most relevant, study I review is on red light therapy's impact on reducing pain and improving function with plantar fasciitis (PF). I've personally never dealt with PF, but I have treated it countless times as a physical therapist and know many other people that have dealt with it -- long story short, it is not fun in the slightest and is incredibly easy for it to become a chronic and/or recurring issue. Red light therapy certainly has a role to play with PF. And, based on my experience, cupping may be one of the BEST modalities in the fight against PF. Did anyone say ReVamp cupping system for combined red light therapy and cupping? As always, enjoy the information and light up your health! -
We will first look at a piece of research that discusses primary mitochondrial diseases (PMDs); however, the article is directed towards physicians and how they can start to recognize patterns and red flags associated with various PMDs (i.e., mitochondrial dysfunction). To me this is extremely exciting in the sense that this type of mitochondrial information is (slowly but surely) permeating its way into the allopathic world. It can't happen fast enough!
The second article looks at methylene blue and a new, yet quite similar synthetic dye salt, blue compound called toluidine blue. The study looks at how when used together, they have a synergistic effect against oral squamous cell carcinoma. I need to know more about toluidine blue!
The third article looks at the effect of transcranial photobiomodulation on concussions. This study is a perfect example of a "non-result" not necessarily being a bad thing or that is should be taken at face value. I will discuss why.
The last, and likely most relevant, study I review is on red light therapy's impact on reducing pain and improving function with plantar fasciitis (PF). I've personally never dealt with PF, but I have treated it countless times as a physical therapist and know many other people that have dealt with it -- long story short, it is not fun in the slightest and is incredibly easy for it to become a chronic and/or recurring issue. Red light therapy certainly has a role to play with PF. And, based on my experience, cupping may be one of the BEST modalities in the fight against PF. Did anyone say ReVamp cupping system for combined red light therapy and cupping? As always, enjoy the information and light up your health! -
Key points:
Introduction and Content Teaser (00:00:16 - 00:01:04:29)
- Dr. Mike's welcome and reflections.
- Teaser for red light therapy, mitochondrial health, and more.
BioLight's Evolution (00:01:04:29 - 00:04:05:09)
- Revamped cupping system introduction.
- Upcoming research coverage.
- BioLight's future and seamless integration.
Vision and Innovation (00:04:05:09 - 00:06:45:01)
- Vision for 2024 and beyond.
- Examples of integrating red light therapy.
- BioLight's new direction and upcoming products.
Mitochondrial Health Focus (00:06:45:04 - 00:08:06:22)
- Integration of methylene blue.
- BioLight as a mitochondrial health company.
Primary Mitochondrial Diseases (00:08:06:24 - 00:14:14:25)
- Introduction to the research article.
- Red flags and manifestations across body systems.
- Conclusion and article promotion.
Mitochondrial Oxidative Phosphorylation (00:18:25:17 - 00:19:32:25)
- Focus on genetically determined impairment.
- Reiteration of manifestations and red flags.
Photodynami